Basal forebrain lesions in monkeys disrupt attention but not learning and memory

Journal of Neuroscience

Volumn 14, Issue 1, 1994, Pages 167-186

  Voytko, Mary Lou ^a,b   Olton, David S ^a   Richardson, Russell T ^a   Gorman, Linda K ^a   Tobin, Joseph R ^a   Price, Donald L ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

attention; basal forebrain; cholinergic system; ibotenic acid; learning; medial septum; memory; monkeys; nucleus basalis of Meynert; nucleus of the diagonal band of Broca

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; IBOTENIC ACID; METHYLSCOPOLAMINE; SCOPOLAMINE;

ALZHEIMER DISEASE; ANIMAL BEHAVIOR; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENTION; BRAIN INJURY; BRAIN NUCLEUS; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; FOREBRAIN; LEARNING; MEMORY; MONKEY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; STEREOTAXIC SURGERY; TASK PERFORMANCE;

EID: 0028069391     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.14-01-00167.1994     Document Type: Article

References (164)

1. Adolfsson R, Gottfries CG, Roos BE, Winblad B (1979) Changes in the brain catecholamines in patients with dementia of Alzheimer type. Br J Psychiatry 135:216-223.
2. Aigner TG, Mishkin M (1986) The effects of physostigmine and scopolamine on recognition memory in monkeys. Behav Neural Biol 45: 81-87.
3. Aigner TG, Mitchell SJ, Aggleton JP, DeLong MR, Struble RG, Price DL, Wenk GL, Mishkin M (1987) Effects of scopolamine and physostigmine on recognition memory in monkeys with ibotenic-acid lesions of the nucleus basalis of Meynert. Psychopharmacology 92: 292-300.
4. Aigner TG, Mitchell SJ, Aggleton JP, DeLong MR, Struble RG, Price DL, Wenk GL, Pettigrew KD, Mishkin M (1991) Transient impairment of recognition memory following ibotenic-acid lesions of the basal forebrain in macaques. Exp Brain Res 86:18-26.
5. Arendt T, Bigl V, Arendt A, Tennstedt A (1983) Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoffs disease. Acta Neuropathol (Berl) 61:101-108.
6. Arnold SE, Hyman BT, Flory J, Damasio AR, Van Hoesen GW (1991) The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb Cortex 1:103-116.
7. Bachevalier J, Mishkin M (1986) Visual recognition impairment follows ventromedial but not dorsolateral prefrontal lesions in monkeys. Behav Brain Res 20:249-261.
8. Bartus RT (1978) Evidence for a direct cholinergic involvement in the scopolamine-induced amnesia in monkeys: effects of concurrent administration of physostigmine and methylphenidate with scopolamine. Pharmacol Biochem Behav 9:833-836.
9. Bartus RT (1982) Effects of cholinergic agents on learning and memory in animal models of aging. In: Aging, Vol 19, Alzheimer's disease: a report of progress in research (Corkin S, Growdon JH, Davis KL, Usdin E, Wurtman RJ, eds), pp 271-280. New York: Raven.
10. Bartus RT, Johnson HR (1976) Short-term memory in the rhesus monkey: disruption from the anti-cholinergic scopolamine. Pharmacol Biochem Behav 5:39-46.
11. Bartus RT, Dean RL, Beer B, Lippa AS (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217:408-417.
12. Bauer RH, Fuster JM (1976) Delayed-matching and delayed-response deficit from cooling dorsolateral prefrontal cortex in monkeys. J Comp Physiol Psychol 90:293-302.
13. Beal MF, Mazurek MF (1987) Substance P-like immunoreactivity is reduced in Alzheimer's disease cerebral cortex. Neurology 37:1205-1209.
14. Beal MF, Mazurek MF, Chattha GK, Svendsen CV, Bird ED, Martin JB (1986) Neuropeptide Y immunoreactivity is reduced in cerebral cortex in Alzheimer's disease. Ann Neurol 20:282-288.
15. Bear MF, Singer W (1986) Modulation of visual cortical plasticity by acetylcholine and noradrenaline. Nature 320:172-176.
16. Beason LL, Moss MB, Rosene DL (1990) Effects of entorhinal, parahippocampal, or basal forebrain lesions on recognition memory in the monkey. Soc Neurosci Abstr 16:617.
17. Bird TD, Stranahan S, Sumi SM, Raskind M (1983) Alzheimer's disease: choline acetyltransferase activity in brain tissue from clinical and pathological subgroups. Ann Neurol 14:284-293.
18. Bondareff W, Mountjoy CQ, Roth M (1982) Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia. Neurology 32:164-168.
19. Bowen DM, Allen SJ, Benton JS, Goodhardt MJ, Haan EA, Palmer AM, Sims NR, Smith CCT, Spillane JA, Esiri MM, Neary D, Snowdon JS, Wilcock GK, Davison AN (1983) Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease. J Neurochem 41:266-272.
20. Buzsáki G, Gage FH (1991) Role of the basal forebrain cholinergic system in cortical activation and arousal. In: Activation to acquisition. Functional aspects of the basal forebrain cholinergic system (Richardson RT, ed), pp 115-133. Boston: Birkhäuser.
21. Candy JM, Perry RH, Perry EK, Irving D, Blessed G, Fairbairn AF, Tomlinson BE (1983) Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases. J Neurol Sci 54:277-289.
22. Capitani E, Della Sala S, Lucchelli F, Soave P, Spinnler H (1988) Perceptual attention in aging and dementia measured by Gottschaldt's hidden figure test. J Gerontol 43:P157-P163.
23. Chow KL, Survis J (1958) Retention of overlearned visual habit after temporal cortical ablation in monkey. AMA Arch Neurol Psychiatry 79:640-646.
24. Connor DJ, Langlais PJ, Thal LJ (1991) Behavioral impairments after lesions of the nucleus basalis by ibotenic acid and quisqualic acid. Brain Res 555:84-90.
25. Cowey A, Gross CG (1970) Effects of foveal prestriate and inferotemporal lesions on visual discrimination by rhesus monkeys. Exp Brain Res 11:128-144.
26. Coyle JT, Price DL, DeLong MR (1983) Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 219:1184-1190.
27. Decker MW, Gallagher M (1987) Scopolamine-disruption of radial arm maze performance: modification by noradrenergic depletion. Brain Res 417:59-69.
28. Decker MW, McGaugh JL (1991) The role of interactions between the cholinergic system and other neuromodulatory systems in learning and memory. Synapse 7:151-168.
29. Decker MW, Gill TM, McGaugh JL (1990) Concurrent muscarinic and β-adrenergic blockade in rats impairs place-learning in a water maze and retention of inhibitory avoidance. Brain Res 513:81-85.
30. Détári L, Vanderwolf CH (1987) Activity of identified cortically projecting and other basal forebrain neurones during large slow waves and cortical activation in anaesthetized rats. Brain Res 437:1-8.
31. Drachman DA (1981) The cholinergic system, memory, and aging. In: Aging, Vol 17, Brain neurotransmitters and receptors in aging and age-related disorders (Enna SJ, Samorajski T, Beer B, eds), pp 255-268. New York: Raven.
32. Dubois B, Ruberg M, Javoy-Agid F, Ploska A, Agid Y (1983) A subcortico-cortical cholinergic system is affected in Parkinson's disease. Brain Res 288:213-218.
33. Dunne MP, Hartley LR (1985) The effects of scopolamine upon verbal memory: evidence for an attentional hypothesis. Acta Psychol 58: 205-217.
34. Dunnett SB, Everitt BJ, Robbins TW (1991) The basal forebraincortical cholinergic system: interpreting the functional consequences of excitotoxic lesions. Trends Neurosci 14:494-501.
35. Eagger SA, Levy R, Sahakian BJ (1991) Tacrine in Alzheimer's disease. Lancet 337:989-992.
36. Flynn DD, Weinstein DA, Mash DC (1991) Loss of high-affinity agonist binding to M1 muscarinic receptors in Alzheimer's disease: implications for the failure of cholinergic replacement therapies. Ann Neurol 29:256-262.
37. Fonnum F (1969) Radiochemical micro assays for the determination of choline acetyltransferase and acetylcholinesterase activities. Biochem J 115:465-472.
38. Freed DM, Corkin S, Growdon JH, Nissen MJ (1989) Selective attention in Alzheimer's disease: characterizing cognitive subgroups of patients. Neuropsychologia 27:325-339.
39. Freedman M, Oscar-Berman M (1986) Selective delayed response deficits in Parkinson's and Alzheimer's disease. Arch Neurol 43:886-890.
40. Fuster JM (1990) Inferotemporal units in selective visual attention and short-term memory. J Neurophysiol 64:681-697.
41. Gaffan D, Murray EA (1992) Monkeys (Macaca fascicularis) with rhinal cortex ablations succeed in object discrimination learning despite 24-hr intertrial intervals and fail at matching to sample despite double sample presentations. Behav Neurosci 106:30-38.
42. George PJ, Horel JA, Cirillo RA (1989) Reversible cold lesions of the parahippocampal gyrus in monkeys result in deficits on the delayed match-to-sample and other visual tasks. Behav Brain Res 34:163-178.
43. Givens BS, Olton DS (1990) Cholinergic and GABAergic modulation of medial septal area: effect on working memory. Behav Neurosci 104:849-855.
44. Goldman PS, Rosvold HE (1970) Localization of function within the dorsolateral prefrontal cortex of the rhesus monkey. Exp Neurol 27: 291-304.
45. Gottfries CG (1990) Neurochemical aspects of dementia disorders. Dementia 1:56-64.
46. Grady CL, Grimes AM, Patronas N, Sunderland T, Foster NL, Rapoport SI (1989) Divided attention, as measured by dichotic speech performance in dementia of the Alzheimer type. Arch Neurol 46:317-320.
47. Greenamyre JT, Young AB (1989) Excitatory amino acids and Alzheimer's disease. Neurobiol Aging 10:593-602.
48. Hagan JJ, Morris RGM (1988) The cholinergic hypothesis of memory: a review of animal experiments. In: Handbook of Psychopharmacology, Vol 20, Psychopharmacology of the aging nervous system (Iversen LL, Iversen SD, Snyder SH, eds), pp 237-323. New York: Plenum.
49. Haxby JV, Parasuraman R, Gillette J, Raffaele K (1991) Selective and divided attention to visual features are impaired in patients with early dementia of the Alzheimer type. Soc Neurosci Abstr 17:696.
50. Hedreen JC, Struble RG, Bacon SJ, Price DL (1983) A new histochemical technique for acetylcholinesterase (AChE) in axons. J Neuropathol Exp Neurol 42:325.
51. Heilman KM, Valenstein E (1985) Clinical neuropsychology, 2d ed. New York: Oxford UP.
52. Henke H, Lang W (1983) Cholinergic enzymes in neocortex, hippocampus and basal forebrain of non-neurological and senile dementia of Alzheimer-type patients. Brain Res 267:281-291.
53. Herrera-Marschitz M, Goiny M, Utsumi H, Ferre S, Håkansson L, Nordberg A, Ungerstedt U (1990) Effect of unilateral nucleus basalis lesion on cortical and striatal acetylcholine and dopamine release monitored in vivo with microdialysis. Neurosci Lett 110:172-179.
54. Horel JA, Voytko ML, Salsbury KG (1984) Visual learning suppressed by cooling the temporal pole. Behav Neurosci 98:310-324.
55. Horel JA, Pytko-Joiner DE, Voytko ML, Salsbury K (1987) The performance of visual tasks while segments of the inferotemporal cortex are suppressed by cold. Behav Brain Res 23:29-42.
56. Iraizoz I, de Lacalle S, Gonzalo LM (1991) Cell loss and nuclear hypertrophy in topographical subdivisions of the nucleus basalis of Meynert in Alzheimer's disease. Neuroscience 41:33-40.
57. Irle E, Markowitsch HJ (1987) Basal forebrain-lesioned monkeys are severely impaired in tasks of association and recognition memory Ann Neurol 22:735-743.
58. Irle E, Kessler J, Markowitsch HJ, Hofmann W (1987) Primate learning tasks reveal strong impairments in patients with presenile or senile dementia of the Alzheimer type. Brain Cogn 6:429-449.
59. Karnovsky MJ, Roots L (1964) A "direct-coloring" thiocholine method for cholinesterase. J Histochem Cytochem 12:219-221.
60. Kemper T (1984) Neuroanatomical and neuropathological changes in normal aging and in dementia. In: Clinical neurology of aging (Albert ML, ed), pp 9-52. New York: Oxford UP.
61. Kesner RP (1988) Reevaluation of the contribution of the basal forebrain cholinergic system to memory. Neurobiol Aging 9:609-616.
62. Kesner RP, Johnson DL (1991) An analysis of the basal forebrain contribution to learning and memory. In: Activation to acquisition. Functional aspects of the basal forebrain cholinergic system (Richardson RT, ed), pp 263-288. Boston: Birkhäuser.
63. Kish SJ, El-Awar M, Schut L, Leach L, Oscar-Berman M, Freedman M (1988) Cognitive deficits in olivopontocerebellar atrophy: implications for the cholinergic hypothesis of Alzheimer's dementia. Ann Neurol 24:200-206.
64. Kish SJ, Robitaille Y, El-Awar M, Deck JHN, Simmons J, Schut L, Chang L-J, DiStefano L, Freedman M (1989) Non-Alzheimer-type pattern of brain cholineacetyltransferase reduction in dominantly inherited olivopontocerebellar atrophy. Ann Neurol 26:362-367.
65. Kitt CA, Mitchell SJ, DeLong MR, Wainer BH, Price DL (1987) Fiber pathways of basal forebrain cholinergic neurons in monkeys. Brain Res 406:192-206.
66. Koshimura K, Kato T, Tohyama I, Nakamura S, Kameyama M (1986) Qualitative abnormalities of choline acetyltransferase in Alzheimer type dementia. J Neurol Sci 76:143-150.
67. Mahut H (1971) Spatial and object reversal learning in monkeys with partial temporal lobe ablations. Neuropsychologia 9:409-424.
68. Mann DMA, Yates PO, Marcyniuk B (1984) Alzheimer's presenile dementia, senile dementia of Alzheimer type and Down's syndrome in middle age form an age related continuum of pathological changes. Neuropathol Appl Neurobiol 10:185-207.
69. Marcyniuk B, Mann DMA, Yates PO (1989) The topography of nerve cell loss from the locus caeruleus in elderly persons. Neurobiol Aging 10:5-9.
70. Markowska AL, Olton DS, Murray EA, Gaffan D (1989) A comparative analysis of the role of fornix and cingulate cortex in memory: rats. Exp Brain Res 74:187-201.
71. Martin-Elkins CL, George P, Horel JA (1989) Retention deficits produced in monkeys with reversible cold lesions in the prestriate cortex. Behav Brain Res 32:219-230.
72. Mash DC, Flynn DD, Potter LT (1985) Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation. Science 228:1115-1117.
73. Mesulam M-M (1983) The functional anatomy and hemispheric specialization for directed attention. The role of the parietal lobe and its connectivity. Trends Neurosci 6:384-387.
74. Mesulam M-M, Geula C (1988) Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain: observations based on the distribution of acetylcholinesterase and choline acetyltransferase. J Comp Neurol 275:216-240.
75. Mesulam M-M, Mufson EJ, Levey AI, Wainer BH (1983) Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey. J Comp Neurol 214:170-197.
76. Mishkin M (1982) A memory system in the monkey. Philos Trans R Soc Lond [Biol] 298:85-95.
77. Mueller PM, Tipper SP, Baylis GC (1991) The effect of normal aging and Alzheimer's disease on spatial attention. Soc Neurosci Abstr 17: 696.
78. Mufson EJ, Kordower JH (1989) Nerve growth factor receptor expressing human basal forebrain neurons: pathologic alterations in Alzheimer's and Parkinson's disease. In: Progress in clinical and biological research, Vol 317, Proceedings of the first international Conference on Alzheimer's disease and related disorders (Iqbal K, Wisniewski HM, Winblad B, eds), pp 401-414. New York: Liss.
79. Muir JL, Dunnett SB, Robbins TW, Everitt BJ (1992) Attentional functions of the forebrain cholinergic systems: effects of intraventricular hemicholinium, physostigmine, basal forebrain lesions and intracortical grafts on a multiple-choice serial reaction time task. Exp Brain Res 89:611-622.
80. Murray EA, Davidson M, Gaffan D, Olton DS, Suomi S (1989) Effects of fornix transection and cingulate cortical ablation on spatial memory in rhesus monkeys. Exp Brain Res 74:173-186.
81. Nagai T, McGeer PL, Peng JH, McGeer EG, Dolman CE (1983) Choline acetyltransferase immunohistochemistry in brains of Alzheimer's disease patients and controls. Neurosci Lett 36:195-199.
82. Nilsson OG, Strecker RE, Daszuta A, Björklund A (1988) Combined cholinergic and serotonergic denervation of the forebrain produces severe deficits in a spatial learning task in the rat. Brain Res 453:235-246.
83. Olton DS (1991) Experimental strategies to identify the neurobiological bases of memory: lesions. In: Learning and memory. A biological view, 2d ed (Martinez JL, Kesner RP, eds), pp 441-466. New York: Academic.
84. Olton DS, Pang K (1992) Interactions of neurotransmitters and neuroanatomy: it's not what you do, it's the place that you do it. In: Neurotransmitter interactions and cognitive function (Levin ED, Decker MW, Butcher LL, eds), pp 277-286. Boston: Birkhäuser.
85. Olton DS, Wenk GL (1987) Dementia: animal models of the cognitive impairments produced by degeneration of the basal forebrain cholinergic system. In: Psychopharmacology: the third generation of progress (Meltzer HY, ed), pp 941-953. New York: Raven.
86. Olton DS, Wenk GL, Church RM, Meek WH (1988) Attention and the frontal cortex as examined by simultaneous temporal processing. Neuropsychologia 26:307-318.
87. Olton D, Markowska A, Voytko ML, Givens B, German L, Wenk G (1991a) Basal forebrain cholinergic system: a functional analysis. In: The basal forebrain: anatomy to function (Napier TC, Kalivas PW, Hanin I, eds), pp 353-372. New York: Plenum.
88. Olton DS, Wenk GL, Markowska AM (1991b) Basal forebrain, memory and attention. In: Activation to acquisition. Functional aspects of the basal forebrain cholinergic system (Richardson RT, ed), pp 247-262. Boston: Birkhäuser.
89. Olton DS, Givens BS, Markowska AL, Shapiro M, Golski S (1991c) Mnemonic functions of the cholinergic septohippocampal system. In: Memory: organization and locus of change (Squire LR, ed), pp 250-269. New York: Oxford UP.
90. Palmer AM, Procter AW, Stratmann GC, Bowen DM (1986) Excitatory amino acid-releasing and cholinergic neurones in Alzheimer's disease. Neurosci Lett 66:199-204.
91. Palmer AM, Wilcock GK, Esiri MM, Francis PT, Bowen DM (1987) Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease. Brain Res 401:231-238.
92. Pang K. Williams MJ, Egeth H, Olton DS (1993) Nucleus basalis magnocellularis (NBM) and attention: effects of muscimol infusions. Behav Neurosci, in press.
93. Parasuraman R, Greenwood PM, Haxby JV, Grady CL (1992) Visuospatial attention in dementia of the Alzheimer type. Brain 115: 711-733.
94. Pascual J. Fontán A, Zarranz JJ, Berciano J, Flórez J, Pazos A (1991) High-affinity choline uptake carrier in Alzheimer's disease: implications for the cholinergic hypothesis of dementia. Brain Res 552:170-174.
95. Penetar DM, McDonough JH (1983) Effects of cholinergic drugs on delayed match-to-sample performance of rhesus monkeys. Pharmacol Biochem Behav 19:963-967.
96. Perry EK, Perry RH, Smith CJ, Purohit D, Bonham J, Dick DJ, Candy JM, Edwardson JA, Fairbairn A (1986) Cholinergic receptors in cognitive disorders. Can J Neurol Sci 13:521-527.
97. Perry RH, Candy JM, Perry EK, Irving D, Blessed G, Fairbairn AF, Tomlinson BE (1982) Extensive loss of choline acetyltransferase activity is not reflected by neuronal loss in the nucleus of Meynert in Alzheimer's disease. Neurosci Lett 33:311-315.
98. Petersen SE, Robinson DL (1986) Damage to parietal cortex produces a similar deficit in man and monkey. Invest Ophthalmol Vis Sci 27[Suppl 3]:18.
99. Petersen SE, Robinson DL, Currie JN (1989) Influences of lesions of parietal cortex on visual spatial attention in humans. Exp Brain Res 76:267-280.
100. Petersen SE, Corbetta M, Shulman GL, Miezin FM (1991) Frontal activation during shifts of visual spatial attention: a pet study. Soc Neurosci Abstr 17:1210.
101. Phillips RR, Malamut BL, Bachevalier J, Mishkin M (1988) Dissociation of the effects of inferior temporal and limbic lesions on object discrimination learning with 24-h intertrial intervals. Behav Brain Res 27:99-107.
102. Posner MI (1980) Orienting of attention. Q J Exp Psychol 32:3-25.
103. Posner MI, Cohen Y (1984) Components of visual orienting. In: Attention and performance. X. Control of language processes (Bouma H, Bouwhuis DG, eds), pp 531-556. London: Erlbaum.
104. Posner MI, Cohen Y, Rafal RD (1982) Neural systems control of spatial orienting. Philos Trans R Soc Lond [Biol] 298:187-198.
105. Posner MI, Walker JA, Friedrich FA, Rafal RD (1984) Effects of parietal injury on covert orienting of attention. J Neurosci 4:1863-1874.
106. Posner MI, Walker JA, Friedrich FA, Rafal RD (1987) How do the parietal lobes direct covert attention? Neuropsychologia 25:135-145.
107. Price DL, Whitehouse PJ, Struble RG, Clark AW, Coyle JT, DeLong MR, Hedreen JC (1982) Basal forebrain cholinergic systems in Alzheimer's disease and related dementias. Neurosci Comment 1:84-92.
108. Price JL, Davis PB, Morris JC, White DL (1991) The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol Aging 12:295-312.
109. Quirion R, Martel JC, Robitaille Y, Etienne P, Wood P, Nair NPV, Gauthier S (1986) Neurotransmitter and receptor deficits in senile dementia of the Alzheimer type. Can J Neurol Sci 13:503-510.
110. Raffaele KC, Olton DS (1988) Hippocampal and amygdaloid involvement in working memory for nonspatial stimuli. Behav Neurosci 102: 349-355.
111. Richardson RT, DeLong MR (1991) Functional implications of tonic and phasic activity changes in nucleus basalis neurons. In: Activation to acquisition. Functional aspects of the basal forebrain cholinergic system (Richardson RT, ed), pp 135-166. Boston: Birkhäuser.
112. Richter-Levin G, Segal M (1989) Spatial performance is severely impaired in rats with combined reduction of serotonergic and cholinergic transmission. Brain Res 477:404-407.
113. Ridley RM, Bowes PM, Baker HF, Crow TJ (1984) An involvement of acetylcholine in object discrimination learning and memory in the marmoset. Neuropsychologia 22:253-263.
114. Ridley RM, Baker HF, Drewett B, Johnson JA (1985) Effects of ibotenic acid lesions of the basal forebrain on serial reversal learning in marmosets. Psychopharmacology 86:438-443.
115. Ridley RM, Murray TK, Johnson JA, Baker HF (1986) Learning impairment following lesion of the basal nucleus of Meynert in the marmoset: modification by cholinergic drugs. Brain Res 376:108-116.
116. Ridley RM, Baker HF, Murray TK (1988a) Basal nucleus lesions in monkeys: recognition memory impairment or visual agnosia? Psychopharmacology 95:289-290.
117. Ridley RM, Samson NA, Baker HF, Johnson JA (1988b) Visuospatial learning impairment following lesion of the cholinergic projection to the hippocampus. Brain Res 456:71-87.
118. Ridley RM, Aitken DM, Baker HF (1989) Learning about rules but not about reward is impaired following lesions of the cholinergic projection to the hippocampus. Brain Res 502:306-318.
119. Riekkinen M, Riekkinen P, Riekkinen P (1991) Comparison of quisqualic and ibotenic acid nucleus basalis magnocellularis lesions on water-maze and passive avoidance performance. Brain Res Bull 27: 119-123.
120. Riekkinen P, Sirviö J, Riekkinen P (1990) Interaction between raphe dorsalis and nucleus basalis magnocellularis in spatial learning. Brain Res 527:342-345.
121. Rinne JO, Paljärvi L, Rinne UK (1987) Neuronal size and density in the nucleus basalis of Meynert in Alzheimer's disease. J Neurol Sci 79:67-76.
122. Robbins TW, Everitt BJ, Marston HM, Wilkinson J, Jones GH, Page KJ (1989) Comparative effects of ibotenic acid-and quisqualic acid-induced lesions of the substantia innominata on attentional function in the rat: further implications for the role of the cholinergic neurons of the nucleus basalis in cognitive processes. Behav Brain Res 35: 221-240.
123. Roberts AC, Robbins TW, Everitt BJ, Jones GH, Sirkia TE, Wilkinson J, Page K (1990) The effects of excitotoxic lesions of the basal forebrain on the acquisition, retention and serial reversal of visual discriminations in marmosets. Neuroscience 34:311-329.
124. Roberts AC, Robbins TW, Everitt BJ, Muir JL (1992) A specific form of cognitive rigidity following excitotoxic lesions of the basal forebrain in marmosets. Neuroscience 47:251-264.
125. Robinson DL, Bowman EM, Kertzman C (1991) Covert orienting of attention in macaque. II. A signal in parietal cortex to disengage attention. Soc Neurosci Abstr 17:442.
126. Rossor M. Iversen LL (1986) Non-cholinergic neurotransmitter abnormalities in Alzheimer's disease. Br Med Bull 42:70-74.
127. Rossor MN, Garrett NJ, Johnson AL, Mountjoy CQ, Roth M, Iversen LL (1982) A post-mortem study of the cholinergic and GABA systems in senile dementia. Brain 105:313-330.
128. Rupniak NMJ, Steventon MJ, Field MJ, Jennings CA, Iversen SD (1989) Comparison of the effects of four cholinomimetic agents on cognition in primates following disruption by scopolamine or by lists of objects. Psychopharmacology 99:189-195.
129. Rye DB, Wainer BH, Mesulam M-M, Mufson EJ, Saper CB (1984) Cortical projections arising from the basal forebrain: a study of cholinergic and noncholinergic components employing combined retrograde tracing and immunohistochemical localization of choline acetyltransferase. Neuroscience 13:627-643.
130. Sahakian BJ (1988) Cholinergic drugs and human cognitive performance. In: Handbook of psychopharmacology, Vol 20, Psychopharmacology of the aging nervous system (Iversen LL, Iversen SD, Snyder SH, eds), pp 393-424. New York: Plenum.
131. Sahakian BJ, Morris RG, Evenden JL, Heald A, Levy R, Philpot M, Robbins TW (1988) A comparative study of visuospatial memory and learning in Alzheimer-type dementia and Parkinson's disease. Brain 111:695-718.
132. Sahakian B, Jones G, Levy R, Gray J, Warburton D (1989) The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type. Br J Psychiatry 154:797-800.
133. Saper CB, German DC, White CL (1985) Neuronal pathology in the nucleus basalis and associated cell groups in senile dementia of the Alzheimer's type: possible role in cell loss. Neurology 35:1089-1095.
134. Sato T (1988) Effects of attention and stimulus interaction on visual responses of inferior temporal neurons in macaque. J Neurophysiol 60:344-364.
135. Saunders RC, Aigner TG, Frank JA (1990) Magnetic resonance imaging of the rhesus monkey brain: use for stereotactic neurosurgery. Exp Brain Res 81:443-446.
136. Scheff SW, DeKosky ST, Price DA (1990) Quantitative assessment of cortical synaptic density in Alzheimer's disease. Neurobiol Aging 11: 29-37.
137. Semba K (1991) The cholinergic basal forebrain: a critical role in cortical arousal. In: The basal forebrain. Anatomy to function (Napier TC, Kalivas PW, Hanin I, eds), pp 197-217. New York: Plenum.
138. Sillito AM, Murphy PC (1987) The cholinergic modulation of cortical function. In: Cerebral cortex, Vol 6, Further aspects of cortical functions including hippocampus (Jones EG, Peters A, eds), pp 161-185. New York: Plenum.
139. Singer W (1979) Central-core control of visual-cortex functions. In: The neurosciences. Fourth study program (Schmitt FO, Worden FG, eds), pp 1093-1110. Cambridge, MA: MIT Press.
140. Spencer DG, Lal H (1983) Effects of anticholinergic drugs on learning and memory. Drug Dev Res 3:489-502.
141. Spinnler H (1991) The role of attention disorders in the cognitive deficits of dementia. In: Handbook of neuropsychology, Vol 5 (Boller F, Grafman J, eds) pp 79-122. Amsterdam: Elsevier.
142. Snitzer H, Desimone R, Moran J (1988) Increased attention enhances both behavioral and neuronal performance. Science 240:338-340.
143. Squire LR, Zola-Morgan S (1991) The medial temporal lobe memory system. Science 253:1380-1386.
144. Struble RG, Lehmann J, Mitchell SJ, McKinney M, Price DL, Coyle JT, DeLong MR (1986) Basal forebrain neurons provide major cholinergic innervation of primate neocortex. Neurosci Lett 66:215-220.
145. Stuss DT, Benson DF (1986) The frontal lobes. New York: Raven.
146. Sunderland T, Tariot PN, Mueller EA, Murphy DL, Weingartner H, Cohen RM (1985a) Cognitive and behavioral sensitivity to scopolamine in Alzheimer patients and controls. Psychopharmacol Bull 21:676-679.
147. Sunderland T, Tariot PN, Murphy DL, Weingartner H, Mueller EA, Cohen RM (1985b) Scopolamine challenges in Alzheimer's disease. Psychopharmacology 87:247-249.
148. Tagliavini F, Pilleri G (1983) Basal nucleus of Meynert. A neuropathological study in Alzheimer's disease, simple senile dementia, Pick's disease and Huntington's chorea. J Neurol Sci 62:243-260.
149. Tagliavini F, Pilleri G, Bouras C, Constantinidis J (1984) The basal nucleus of Meynert in idiopathic Parkinson's disease. Acta Neurol Scand 69:20-28.
150. Tsuji S (1974) On the chemical basis of thiocholine methods for demonstration of acetylcholinesterase activities. Histochemistry 42:99-110.
151. Vanderwolf CH (1987) Near-total loss of "learning" and "memory" as a result of combined cholinergic and serotonergic blockade in the rat. Behav Brain Res 23:43-57.
152. Vogels OJM, Broere CAJ, Ter Laak HJ, Ten Donkelaar HJ, Nieuwenhuys R, Schulte BPM (1990) Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer's disease. Neurobiol Aging 11: 3-13.
153. Voytko ML (1985) Cooling orbital frontal cortex disrupts matching-to-sample and visual discrimination learning in monkeys. Physiol Psychol 13:219-229.
154. Voytko ML (1986) Visual learning and retention examined with reversible cold lesions of the anterior temporal lobe. Behav Brain Res 22:25-39.
155. Voytko ML, Kitt CA, Price DL (1992) Cholinergic immunoreactive fibers in monkey anterior temporal cortex. Cereb Cortex 2:48-55.
156. Wenk GL, Harrington CA, Tucker DA, Rance NE, Walker LC (1992) Basal forebrain neurons and memory: a biochemical, histological, and behavioral study of differential vulnerability to ibotenate and quisqualate. Behav Neurosci 106:909-923.
157. Wesnes K, Warburton DM (1983) Effects of scopolamine on stimulus sensitivity and response bias in a visual vigilance task. Neuropsychobiology 9:154-157.
158. Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, DeLong MR (1982) Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 215:1237-1239.
159. Wilcock GK, Esiri MM, Bowen DM, Smith CCT (1982) Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities. J Neurol Sci 57:407-417.
160. Wilcock GK, Esiri MM, Bowen DM, Hughes AO (1988) The differential involvement of subcortical nuclei in senile dementia of Alzheimer's type. J Neurol Neurosurg Psychiatry 51:842-849.
161. Yamamoto T, Hirano A (1985) Nucleus raphe dorsalis in Alzheimer's disease: neurofibrillary tangles and loss of large neurons. Ann Neurol 17:573-577.
162. Zola-Morgan S, Squire LR (1986) Memory impairment in monkeys following lesions limited to the hippocampus. Behav Neurosci 100: 155-160.
163. Zola-Morgan S, Squire LR, Amaral DG (1989a) Lesions of the hippocampal formation but not lesions of the fornix or the mammillary nuclei produce long-lasting memory impairment in monkeys. J Neurosci 9:898-913.
164. Zola-Morgan S, Squire LR, Amaral DG, Suzuki WA (1989b) Lesions of perirhinal and parahippocampal cortex that spare the amygdala and hippocampal formation produce severe memory impairment. J Neurosci 9:4355-4370.